2022 UPMC Heart and Vascular Institute Heart Valve Symposium: Structural Heart Disease Section

The UPMC Heart and Vascular Institute Heart Valve Symposium is an annual CME-accredited symposium featuring a range of discussions about the latest advancements in diagnosis, treatment, and management for patients with complex valve and structural heart disease. The 2022 symposium included in-depth discussions about transcatheter aortic valve replacement (TAVR), the future of surgical aortic valve replacement, mitral and tricuspid valve disease, minimally invasive and robotic cardiac surgery, and more. 

View the presentations focusing on structural heart disease here.

For more information or to refer a patient, please email HVIReferral@upmc.edu.

Section 3: Structural Heart Disease – What Does the Future Look Like? Moderated by Ibrahim Sultan, MD

• When is the heart too far gone for valve intervention? Role of mechanical circulatory support
  • Presented by: David J. Kaczorowski, MD

• State of the Art: Update on heart valve guidelines
  • Presented by: Danny Chu, MD

• Mechanical circulatory support during structural interventions: What is my algorithm?
  • Presented by: Robert Maholic, DO

• Referral for heart valve disease interventions: Do we need to lower the threshold?
  • Presented by: Matt Suffoletto, MD

• Transcatheter pulmonary valve replacement in adults with congenital heart disease
  • Presented by: Bryan Goldstein, MD

• Maintaining excellence in heart valve therapies – Role of the heart team
  • Presented by: Lisa Henry, DNP, CRNP, FACC

• What upcoming clinical trials will be game changing for heart valve disease?
  • Presented by: Hemal Gada, MD

• Final panel discussion
  • Moderators: Francis D. Ferdinand, MD; Beth Piccione, MD; Suresh Mulukutla, MD; Derek Serna-Gallegos, MD

View the Aortic Valve Disease session presentations here and the Mitral and Tricuspid Valve Disease session presentations here.